Analyzing Pro-Dex (NASDAQ:PDEX) and Cytosorbents (NASDAQ:CTSO)
Pro-Dex (NASDAQ:PDEX – Get Rating) and Cytosorbents (NASDAQ:CTSO – Get Rating) are both small-cap medical companies, but which is the superior investment? We will contrast the two businesses based on the strength of their analyst recommendations, valuation, profitability, dividends, institutional ownership, risk and earnings. Risk and Volatility Pro-Dex has a beta of 0.99, meaning that […]
Source: modernreaders.com